TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+6.18%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.03B
AUM Growth
+$2.03B
(+87%)
Cap. Flow
+$850M
Cap. Flow
% of AUM
41.76%
Top 10 Holdings %
Top 10 Hldgs %
48.77%
Holding
95
New
29
Increased
37
Reduced
1
Closed
2
Top Buys
| 1 |
Gilead Sciences
GILD
|
$105M |
| 2 |
CELG
Celgene Corp
CELG
|
$104M |
| 3 |
Pfizer
PFE
|
$46.3M |
| 4 |
Johnson & Johnson
JNJ
|
$34.9M |
| 5 |
AbbVie
ABBV
|
$27.8M |
Top Sells
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
$10.9M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$2.27M |
| 3 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$1K |
Sector Composition
| 1 | Healthcare | 85.81% |
| 2 | Real Estate | 2.51% |
| 3 | Financials | 1.55% |
